- Home
- RNAZ vs BBGI Comparison
RNAZ vs BBGI Comparison
Compare RNAZ & BBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- BBGI
- Stock Information
- Founded
- RNAZ 2016
- BBGI 1961
- Country
- RNAZ United States
- BBGI United States
- Employees
- RNAZ N/A
- BBGI N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- BBGI Broadcasting
- Sector
- RNAZ Health Care
- BBGI Consumer Discretionary
- Exchange
- RNAZ Nasdaq
- BBGI Nasdaq
- Market Cap
- RNAZ 8.7M
- BBGI 10.0M
- IPO Year
- RNAZ 2021
- BBGI 2000
- Fundamental
- Price
- RNAZ $15.00
- BBGI $6.00
- Analyst Decision
- RNAZ Strong Buy
- BBGI
- Analyst Count
- RNAZ 1
- BBGI 0
- Target Price
- RNAZ $280.00
- BBGI N/A
- AVG Volume (30 Days)
- RNAZ 13.8K
- BBGI 49.8K
- Earning Date
- RNAZ 11-13-2025
- BBGI 11-04-2025
- Dividend Yield
- RNAZ N/A
- BBGI N/A
- EPS Growth
- RNAZ N/A
- BBGI N/A
- EPS
- RNAZ N/A
- BBGI N/A
- Revenue
- RNAZ N/A
- BBGI $227,387,784.00
- Revenue This Year
- RNAZ N/A
- BBGI $5.02
- Revenue Next Year
- RNAZ N/A
- BBGI N/A
- P/E Ratio
- RNAZ N/A
- BBGI N/A
- Revenue Growth
- RNAZ N/A
- BBGI N/A
- 52 Week Low
- RNAZ $6.15
- BBGI $3.67
- 52 Week High
- RNAZ $739.20
- BBGI $14.95
- Technical
- Relative Strength Index (RSI)
- RNAZ 84.37
- BBGI 59.90
- Support Level
- RNAZ $10.32
- BBGI $5.21
- Resistance Level
- RNAZ $12.28
- BBGI $5.75
- Average True Range (ATR)
- RNAZ 0.87
- BBGI 0.37
- MACD
- RNAZ 0.57
- BBGI -0.02
- Stochastic Oscillator
- RNAZ 91.34
- BBGI 36.37
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.
About BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.